<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1226</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Genetic polymorphisms of innate immunity in adult patients with bronchial asthma</article-title><trans-title-group xml:lang="ru"><trans-title>Генетический полиморфизм рецепторов врожденного иммунитета у взрослых пациентов с бронхиальной астмой</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Barycheva</surname><given-names>L Yu</given-names></name><name xml:lang="ru"><surname>Барычева</surname><given-names>Л Ю</given-names></name></name-alternatives><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shushanova</surname><given-names>L V</given-names></name><name xml:lang="ru"><surname>Шушанова</surname><given-names>Л В</given-names></name></name-alternatives><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kuzmina</surname><given-names>E S</given-names></name><name xml:lang="ru"><surname>Кузьмина</surname><given-names>Е С</given-names></name></name-alternatives><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Medvedenko</surname><given-names>Ju N</given-names></name><name xml:lang="ru"><surname>Медведенко</surname><given-names>Ю Н</given-names></name></name-alternatives><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">FGBO VO «Stavropol state medical university» Health Ministry of Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Ставропольский государственный медицинский университет» Министерства Здравоохранения Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2019</year></pub-date><volume>16</volume><issue>1S</issue><issue-title xml:lang="en">VOL 16, NOS1 (2019)</issue-title><issue-title xml:lang="ru">ТОМ 16, №S1 (2019)</issue-title><fpage>28</fpage><lpage>29</lpage><history><date date-type="received" iso-8601-date="2020-04-02"><day>02</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Фармарус Принт Медиа</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-11-01"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/1226">https://rusalljournal.ru/raj/article/view/1226</self-uri><abstract xml:lang="en"><p>.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Alexis N. E. Biomarker sampling of the airways in asthma. Curr. Opin. Pulm. Med. 2014;20(1):46-52. https:/ doi:10.1097/MCP. 0000000000000010</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Maisonneuve C., Bertholet S., Philpott D. J., De Gregorio E. Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants. Proc. Sci. 2014;111(34):12294-12299. https:/doi:10.1073/ pnas.1400478111</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Sathish V., Thompson M. A., Sinha S., Sieck G. C. Prakash Y. S., Pabelick C. M. Inflammation, caveolae and CD38-mediated calcium regulation in human airway smooth muscle // Biochim. Biophys Acta. 2014;1843(2): 346-351. https://doi.org/10.1016/j.bbamcr.2013.11.011</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Koponen P., Vuononvirta J., Nuolivirta K., Helminen M., He Q., Korppi M. The association of genetic variants in toll-like receptor 2 subfamily with allergy and asthma after hospitalization for bronchiolitis in infancy. Pediatric Infect. Dis. J. 2014;33:463-466 https://doi:10.1097/ INF.0000000000000253.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kormann M. S, Depner M., Hartl D., Klopp N., Illig T., Adamski J. Vogelberg C., Weiland S. K., von Mutius E., Kabesch M. Toll-like receptor heterodimer variants protect from childhood asthma. J. Allergy Clin. Immunol. 2008;122:86-92. https://doi: 10.1016/j.jaci.2008.04.039</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Tabas, I., Glass C. K. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science (80). 2013; 339:166-172. https:doi: 10.1126/ science.1230720</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lau M.Y., Dharmage S.C., Burgess J.A., Win A.K., Lowe A.J., Lodge C., Perret J., Hui J., Thomas P.S., Morrison S., Giles G.G., Hopper J., Abramson M.J., Walters E.H., Matheson M.C. The interaction between farming/rural environment and TLR2, TLR4, TLR6 and CD14 genetic polymorphisms in relation to early-and late-onset asthma. Scientific Reports Published. Scientific Reports. 2017; 7: 1-9. https://doi: 10.1038/ srep43681.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Bortolatto J., Borducchi E., Rodriguez D., Keller A.C., Faquim-Mauro E., Bortoluci K.R., Mucida D., Gomes E., Christ A., Schnyder-Candrian S., Schnyder B., Ryffel B., Russo M. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis. Clin Exp Allergy. 2008; 38: 1668-1679. https:// doi: 10.1111/j.1365-2222.2008.03036.x. Epub 2008 Jun 25.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Texereau J., Chiche J.D., Taylor W., Choukroun G., Comba B., Mira J.P. The Importance of Toll-Like Receptor 2 Polymorphisms in Severe Infections. Clinical Infectious Diseases. 2005; 41: 408-415.</mixed-citation></ref></ref-list></back></article>
